Table 1 Demographic and clinical characteristics of study subjects

From: Gut microbiome is not associated with mild cognitive impairment in Parkinson’s disease

Characteristica

Control, N = 90b

PD-NC, N = 60b

PD-MCI, N = 58b

p-valuec

Control vs. PD-MCId

Control vs. PD-NCd

PD-NC vs. PD-MCId

Female sex

39 (43%)

20 (33%)

19 (33%)

0.315

   

Constipation

6 (6.7%)

25 (42%)

28 (48%)

<0.001

   

Age (years)

68.9 (66.1, 72.5)

71.3 (69.2, 74.9)

73.1 (68.8, 77.9)

0.002

0.001

0.078

0.162

MoCA

28 (27, 29)

28 (27, 29)

23 (22, 25)

<0.001

<0.001

0.777

<0.001

Body mass index

26.8 (24.1, 29.3)

27.6 (24.1, 30.3)

27.7 (25.3, 31.3)

0.055

0.060

0.276

0.427

Years of education

14 (11, 17)

14 (12, 17)

12 (10, 15)

0.061

0.092

0.714

0.092

Caffeine use

84 (93%)

53 (88%)

55 (95%)

0.449

   

Spouse in current data

7 (7.8%)

4 (6.7%)

1 (1.7%)

0.309

   

Probiotics in last 6 months

3 (3.3%)

2 (3.3%)

1 (1.7%)

>0.999

   

Antibiotics in last 6 months

11 (12%)

9 (15%)

3 (5.2%)

0.211

   

Vegan or vegetarian diet

2 (2.2%)

3 (5.0%)

2 (3.4%)

0.638

   

Years since PD diagnosis

 

5 (3, 9)

4 (2, 8)

0.400

   

Levodopa equivalent daily dosage (mg/day)

 

475 (339, 806)

472 (300, 874)

0.988

   

MDS-UPDRS III

 

34 (21, 42)

32 (26, 43)

0.833

   

Hoehn and Yahr stage

 

2.00 (2.00, 2.50)

2.00 (2.00, 2.50)

0.978

   
  1. aMoCA Montreal Cognitive Assessment score, MDS-UPDRS Movement Disorder Society Unified Parkinson’s Disease Rating Scale.
  2. bCategorical variables: n (%); continuous variables: median (IQR).
  3. cCategorical variables: Pearson’s Chi-squared test or Fisher’s exact test; Continuous variables: one-way ANOVA; PD-only continuous variables: Welch two sample t-test.
  4. dpairwise t-test with Holm multiple comparison correction.